Alnylam Pharmaceuticals Statistics
Total Valuation
ALNY has a market cap or net worth of $22.11 billion. The enterprise value is $21.51 billion.
| Market Cap | 22.11B |
| Enterprise Value | 21.51B |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALNY has 133.94 million shares outstanding. The number of shares has increased by 3.63% in one year.
| Current Share Class | 133.94M |
| Shares Outstanding | 133.94M |
| Shares Change (YoY) | +3.63% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 100.40% |
| Float | 133.62M |
Valuation Ratios
The trailing PE ratio is 8.56 and the forward PE ratio is 22.80.
| PE Ratio | 8.56 |
| Forward PE | 22.80 |
| PS Ratio | 4.41 |
| Forward PS | 3.49 |
| PB Ratio | 6.13 |
| P/TBV Ratio | 6.13 |
| P/FCF Ratio | 27.42 |
| P/OCF Ratio | 23.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.83, with an EV/FCF ratio of 26.68.
| EV / Earnings | 8.12 |
| EV / Sales | 4.29 |
| EV / EBITDA | 20.83 |
| EV / EBIT | 22.01 |
| EV / FCF | 26.68 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.83.
| Current Ratio | 2.48 |
| Quick Ratio | 2.26 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 2.69 |
| Debt / FCF | 3.72 |
| Interest Coverage | 3.25 |
Financial Efficiency
Return on equity (ROE) is 138.07% and return on invested capital (ROIC) is 48.31%.
| Return on Equity (ROE) | 138.07% |
| Return on Assets (ROA) | 9.51% |
| Return on Invested Capital (ROIC) | 48.31% |
| Return on Capital Employed (ROCE) | 16.48% |
| Weighted Average Cost of Capital (WACC) | 6.83% |
| Revenue Per Employee | $2.01M |
| Profits Per Employee | $1.06M |
| Employee Count | 2,500 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 12.57 |
Taxes
| Income Tax | -1.87B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.55% in the last 52 weeks. The beta is 0.44, so ALNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -63.55% |
| 50-Day Moving Average | 219.25 |
| 200-Day Moving Average | 275.49 |
| Relative Strength Index (RSI) | 34.62 |
| Average Volume (20 Days) | 3,285,247 |
Short Selling Information
The latest short interest is 5.47 million, so 4.08% of the outstanding shares have been sold short.
| Short Interest | 5.47M |
| Short Previous Month | 6.57M |
| Short % of Shares Out | 4.08% |
| Short % of Float | 4.09% |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, ALNY had revenue of $5.01 billion and earned $2.65 billion in profits. Earnings per share was $19.29.
| Revenue | 5.01B |
| Gross Profit | 3.87B |
| Operating Income | 977.59M |
| Pretax Income | 781.53M |
| Net Income | 2.65B |
| EBITDA | 1.03B |
| EBIT | 977.59M |
| Earnings Per Share (EPS) | $19.29 |
Balance Sheet
The company has $3.59 billion in cash and $3.00 billion in debt, with a net cash position of $590.40 million or $4.41 per share.
| Cash & Cash Equivalents | 3.59B |
| Total Debt | 3.00B |
| Net Cash | 590.40M |
| Net Cash Per Share | $4.41 |
| Equity (Book Value) | 3.60B |
| Book Value Per Share | 26.92 |
| Working Capital | 3.05B |
Cash Flow
In the last 12 months, operating cash flow was $955.94 million and capital expenditures -$149.64 million, giving a free cash flow of $806.31 million.
| Operating Cash Flow | 955.94M |
| Capital Expenditures | -149.64M |
| Depreciation & Amortization | 55.43M |
| Net Borrowing | -52.93M |
| Free Cash Flow | 806.31M |
| FCF Per Share | $6.02 |
Margins
Gross margin is 77.28%, with operating and profit margins of 19.50% and 52.85%.
| Gross Margin | 77.28% |
| Operating Margin | 19.50% |
| Pretax Margin | 15.59% |
| Profit Margin | 52.85% |
| EBITDA Margin | 20.61% |
| EBIT Margin | 19.50% |
| FCF Margin | 16.08% |
Dividends & Yields
ALNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.63% |
| Shareholder Yield | -3.63% |
| Earnings Yield | 11.69% |
| FCF Yield | 3.65% |
Analyst Forecast
The average price target for ALNY is $299.96, which is 81.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $299.96 |
| Price Target Difference | 81.75% |
| Analyst Consensus | Buy |
| Analyst Count | 30 |
| Revenue Growth Forecast (3Y) | 27.30% |
| EPS Growth Forecast (3Y) | 35.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALNY has an Altman Z-Score of 6.83 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.83 |
| Piotroski F-Score | 5 |